| Mar 26 | Mar 25 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | zł 0.00 | zł 0.00 | zł 0.00 | zł 0.00 | zł 0.00 |
| Gross Profit | zł -680.06K | zł -574.43K | - | zł -445.38K | zł -376.98K |
| Operating Income | zł -17.32M | zł -18.83M | zł -15.82M | zł -9.67M | zł -6.21M |
| EBITDA | zł -16.64M | zł -14.04M | zł -13.22M | zł -8.49M | zł -3.95M |
| Net Income | zł -15.16M | zł -14.90M | zł -13.69M | zł -8.92M | zł -4.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | zł 68.40M | zł 33.63M | zł 9.31M | zł 4.12M | zł 6.05M |
| Total Assets | zł 75.63M | zł 41.85M | zł 12.74M | zł 5.99M | zł 8.20M |
| Total Debt | zł 314.90K | zł 823.92K | zł 175.06K | zł 293.94K | zł 530.83K |
| Net Debt | zł -68.09M | zł -32.81M | zł -9.14M | zł -3.83M | zł -5.52M |
| Total Liabilities | zł 2.36M | zł 3.44M | zł 2.27M | zł 2.50M | zł 2.20M |
| Stockholders' Equity | zł 73.28M | zł 38.42M | zł 10.47M | zł 5.15M | zł 6.00M |
| Cash Flow | |||||
| Free Cash Flow | zł -14.07M | zł -17.98M | zł -15.21M | zł -8.26M | zł -4.05M |
| Operating Cash Flow | zł -12.10M | zł -17.74M | zł -14.75M | zł -7.91M | zł -4.04M |
| Investing Cash Flow | zł -1.97M | zł -84.24K | zł -458.35K | zł -351.73K | zł 134.06K |
| Financing Cash Flow | zł 48.84M | zł 42.14M | zł 20.40M | zł 6.32M | zł 6.76M |
Bioceltix SA Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.